Compare Rio Tinto (ADR) (RIO) vs Viatris Inc (VTRS) Price & Performance

Rio Tinto (ADR)Trade

Viatris IncTrade

Price performance (Past 24H)

Key statistics

Rio Tinto (ADR) vs Viatris Inc — how do they compare? Rio Tinto (ADR) trades at $93.94 (market cap $150.89B), while Viatris Inc trades at $17.39 (market cap $20.03B). The key difference: Rio Tinto (ADR) is far larger — about 7.5× Viatris Inc's market cap, and Rio Tinto (ADR) pays the higher dividend (4.98%). Which is the better fit depends on your goals — on Pluang, investors hold Rio Tinto (ADR) for 10 Days and Viatris Inc for 57 Days on average.

	RIO	VTRS
Market Cap	$150.89B	$20.03B
Volume	1,492,444	14,109,977
Sector	Basic Materials	Health
52-Week High	$112.04	$18.27
52-Week Low	$65.44	$9.74
Typical Hold Time	10 Days	57 Days
Enterprise Value	$164.24B	$32.15B
Dividend Yield	4.98%	2.75%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rio Tinto (ADR)

No Aura AI signal available yet.

Viatris Inc

Viatris (VTRS) trades at $17.49, down 0.29% with a bullish technical signal supported by moving averages and oversold RSI levels. The company shows consistent earnings beats with Q2 2026 EPS of $0.69 exceeding expectations, while maintaining strong operational cash flow of $2.32B in 2025. Recent developments include FDA approval for WAKIX in Japan and continued recognition as a top employer.

Despite negative net margins, Viatris demonstrates improving cash flow trends and strategic portfolio optimization. The stock offers 27% upside to consensus price target of $22.17, though investors face risks from debt levels and competitive pressures in the generic drug market. Deleveraging progress and pipeline advancements support potential re-rating.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RIO

Fieldstone Bio joins Rio Tinto accelerator to advance biosensor tech for faster mineral exploration.Unknown · 1 day agoBullish Deutsche Bank raises targets on UK miners amid expected copper supply squeeze in 2027Proactive Investors · 2 days agoBullish Iron ore shipments rise for BHP and Rio Tinto despite prices hitting decade lows due to weak Chinese demand.Proactive Investors · 3 days agoNeutral View details →

VTRS

Pacira BioSciences downgraded after Viatris announces $1.65B acquisition deal.Stuart Mooney · 22 hours agoNeutral Viatris to report Q3 2026 earnings on Nov 5 with live webcast for investors.PRNewsWire · 4 days agoNeutral View details →

About Rio Tinto (ADR)

Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).